This product is a recombinant mouse antibody that recognizes ITGA2. The antibody was purified by affinity chromatography. It can be used in IP, WB, FC.
Figure 1 Identifcation of ITGA2 as a molecular target for GBM.
Representative microscopic images of immunofuorescent staining of ITGA2 in GBM and SVG-P12 cells. Scale bars represent 50 µm.
Guo, P., Moses-Gardner, A., Huang, J., Smith, E. R., & Moses, M. A. (2019). ITGA2 as a potential nanotherapeutic target for glioblastoma. Scientific reports, 9(1), 1-10.
Figure 2 Identifcation of ITGA2 as a molecular target for GBM.
Cell membrane expression levels of ITGA2 and EGFR in GBM and SVG-P12 cells using fow cytometry analysis, showing increased tumorspecifcity of ITGA2 expression on GBM cells as compared to both control cells and also to the current GBM marker, EGFR.
Guo, P., Moses-Gardner, A., Huang, J., Smith, E. R., & Moses, M. A. (2019). ITGA2 as a potential nanotherapeutic target for glioblastoma. Scientific reports, 9(1), 1-10.
Figure 3 Terapeutic functions of ITGA2 blockade.
The effect of ITGA2 antibody on GBM cell proliferation.
Guo, P., Moses-Gardner, A., Huang, J., Smith, E. R., & Moses, M. A. (2019). ITGA2 as a potential nanotherapeutic target for glioblastoma. Scientific reports, 9(1), 1-10.
Figure 4 GBM-targeted therapy of ITGA2-Dox-LP.
Cytotoxicity of ITGA2-LP (vehicle), IgG-Dox-LP, and ITGA2-Dox-LP in A172 cells.
Guo, P., Moses-Gardner, A., Huang, J., Smith, E. R., & Moses, M. A. (2019). ITGA2 as a potential nanotherapeutic target for glioblastoma. Scientific reports, 9(1), 1-10.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-251 | Anti-Human ITGA2 Recombinant Antibody (Vatelizumab) | IF, IP, Neut, FuncS, ELISA, FC, ICC | IgG4 - kappa |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-714LC | Mouse Anti-ITGA2 Recombinant Antibody (TAB-714LC) | ELISA | Mouse IgG |
TAB-715LC | Mouse Anti-ITGA2 Recombinant Antibody (TAB-715LC) | ELISA | Mouse IgG |
TAB-716LC | Mouse Anti-ITGA2 Recombinant Antibody (TAB-716LC) | ELISA | Mouse IgG |
TAB-714LC-F(E) | Mouse Anti-ITGA2 Recombinant Antibody; Fab Fragment (TAB-714LC-F(E)) | ELISA | Mouse Fab |
TAB-715LC-F(E) | Mouse Anti-ITGA2 Recombinant Antibody; Fab Fragment (TAB-715LC-F(E)) | ELISA | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2261MZ | Recombinant Mouse Anti-Human ITGA2 Antibody | WB | Mouse antibody |
HPAB-0312-CN | Mouse Anti-ITGA2 Recombinant Antibody (HPAB-0312-CN) | ELISA, IHC, Block | Mouse IgG1, κ |
HPAB-0313-CN | Human Anti-ITGA2 Recombinant Antibody (HPAB-0313-CN) | ELISA | Chimeric (mouse/human) IgG1, κ |
MRO-0847-CN | Recombinant Rabbit Anti-ITGA2 Monoclonal Antibody (CBACN-309) | WB, IF, IHC, IP, FC | Rabbit IgG |
FN-219CQ | Recombinant Armenian hamster Anti-ITGA2 Antibody (HMa2) | FC, FuncS | Armenian hamster IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-0293MZ | Chicken Anti-ITGA2 Polyclonal IgY | WB | Chicken antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1542CQ | Recombinant Mouse Anti-ITGA2 Antibody (HAS-4) | FC, IHC-Fr, ICC, IP, BL | IgG2a, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1543CQ | Recombinant Mouse Anti-ITGA2 Antibody (P1E6-C5) | FC, BL, IP, ELISA | IgG1, κ |
NEUT-1544CQ | Recombinant Armenian Hamster Anti-Itga2 Antibody (HMα2) | FC, IF, IP, BL | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-1871 | Hi-Affi™ Recombinant Rabbit Anti-ITGA2 Monoclonal Antibody (DS1871AB) | ICC, WB | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0312-CN-S(P) | Mouse Anti-ITGA2 Recombinant Antibody; scFv Fragment (HPAB-0312-CN-S(P)) | ELISA, IHC, Block | Mouse scFv |
HPAB-0313-CN-S(P) | Human Anti-ITGA2 Recombinant Antibody; scFv Fragment (HPAB-0313-CN-S(P)) | ELISA | Human scFv |
HPAB-0314-CN-S(P) | Human Anti-ITGA2 Recombinant Antibody; scFv Fragment (HPAB-0314-CN-S(P)) | ELISA | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0312-CN-F(E) | Mouse Anti-ITGA2 Recombinant Antibody; Fab Fragment (HPAB-0312-CN-F(E)) | ELISA, IHC, Block | Mouse Fab |
HPAB-0313-CN-F(E) | Human Anti-ITGA2 Recombinant Antibody; Fab Fragment (HPAB-0313-CN-F(E)) | ELISA | Human Fab |
HPAB-0314-CN-F(E) | Human Anti-ITGA2 Recombinant Antibody; Fab Fragment (HPAB-0314-CN-F(E)) | ELISA | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-251 | Afuco™ Anti-ITGA2 ADCC Recombinant Antibody (Vatelizumab), ADCC Enhanced | IF, IP, Neut, FuncS, ELISA, FC | ADCC enhanced antibody |
There are currently no Customer reviews or questions for FAMAB-1182CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.